@article{TCR17250,
author = {Mark C. de Gooijer and Olaf van Tellingen},
title = {Have we considered all barriers to mammalian target of rapamycin inhibition as treatment for diffuse intrinsic pontine glioma?},
journal = {Translational Cancer Research},
volume = {6},
number = {Suppl 9},
year = {2017},
keywords = {},
abstract = {Diffuse intrinsic pontine glioma (DIPG) is a uniformly lethal primary pediatric brain tumor (1,2). Surgical resection is impossible due to its location in the brainstem and invasive nature. Radiotherapy provides just a minor incremental extension in overall survival, whereas chemotherapy is largely ineffective (3-5). There is thus a high unmet need for better therapies.},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/17250}
}